220 related articles for article (PubMed ID: 33939629)
21. Impact of praziquantel mass drug administration campaign on prevalence and intensity of Schistosoma haemamtobium among school children in Bahi district, Tanzania.
Chaula SA; Tarimo DS
Tanzan J Health Res; 2014 Jan; 16(1):1-8. PubMed ID: 26867266
[TBL] [Abstract][Full Text] [Related]
22. Prospective, observational study to assess the performance of CAA measurement as a diagnostic tool for the detection of Schistosoma haematobium infections in pregnant women and their child in Lambaréné, Gabon: study protocol of the freeBILy clinical trial in Gabon.
Honkpehedji YJ; Adegnika AA; Dejon-Agobe JC; Zinsou JF; Mba RB; Gerstenberg J; Rakotozandrindrainy R; Rakotoarivelo RA; Rasamoelina T; Sicuri E; Schwarz NG; Corstjens PLAM; Hoekstra PT; van Dam GJ; Kreidenweiss A;
BMC Infect Dis; 2020 Sep; 20(1):718. PubMed ID: 32993559
[TBL] [Abstract][Full Text] [Related]
23. Praziquantel coverage in schools and communities targeted for the elimination of urogenital schistosomiasis in Zanzibar: a cross-sectional survey.
Knopp S; Person B; Ame SM; Ali SM; Muhsin J; Juma S; Khamis IS; Rabone M; Blair L; Fenwick A; Mohammed KA; Rollinson D
Parasit Vectors; 2016 Jan; 9():5. PubMed ID: 26727915
[TBL] [Abstract][Full Text] [Related]
24. "We know about schistosomiasis but we know nothing about FGS": A qualitative assessment of knowledge gaps about female genital schistosomiasis among communities living in Schistosoma haematobium endemic districts of Zanzibar and Northwestern Tanzania.
Mazigo HD; Samson A; Lambert VJ; Kosia AL; Ngoma DD; Murphy R; Matungwa DJ
PLoS Negl Trop Dis; 2021 Sep; 15(9):e0009789. PubMed ID: 34591872
[TBL] [Abstract][Full Text] [Related]
25. Impact of Different Mass Drug Administration Strategies for Gaining and Sustaining Control of
King CH; Kittur N; Binder S; Campbell CH; N'Goran EK; Meite A; Utzinger J; Olsen A; Magnussen P; Kinung'hi S; Fenwick A; Phillips AE; Gazzinelli-Guimaraes PH; Dhanani N; Ferro J; Karanja DMS; Mwinzi PNM; Montgomery SP; Wiegand RE; Secor WE; Hamidou AA; Garba A; Colley DG
Am J Trop Med Hyg; 2020 Jul; 103(1_Suppl):14-23. PubMed ID: 32400356
[TBL] [Abstract][Full Text] [Related]
26. Association between cervical dysplasia and female genital schistosomiasis diagnosed by genital PCR in Zambian women.
Rafferty H; Sturt AS; Phiri CR; Webb EL; Mudenda M; Mapani J; Corstjens PLAM; van Dam GJ; Schaap A; Ayles H; Hayes RJ; van Lieshout L; Hansingo I; Bustinduy AL
BMC Infect Dis; 2021 Jul; 21(1):691. PubMed ID: 34273957
[TBL] [Abstract][Full Text] [Related]
27. Preparing for national school-based deworming in Kenya: the validation and large-scale distribution of school questionnaires with urinary schistosomiasis.
Kihara J; Mwandawiro C; Waweru B; Gitonga CW; Brooker S
Trop Med Int Health; 2011 Oct; 16(10):1326-33. PubMed ID: 21767334
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of integrated interventions layered on mass drug administration for urogenital schistosomiasis elimination: a cluster-randomised trial.
Knopp S; Person B; Ame SM; Ali SM; Hattendorf J; Juma S; Muhsin J; Khamis IS; Mohammed KA; Utzinger J; Hollenberg E; Kabole F; Rollinson D
Lancet Glob Health; 2019 Aug; 7(8):e1118-e1129. PubMed ID: 31255591
[TBL] [Abstract][Full Text] [Related]
29. A 5-Year intervention study on elimination of urogenital schistosomiasis in Zanzibar: Parasitological results of annual cross-sectional surveys.
Knopp S; Ame SM; Person B; Hattendorf J; Rabone M; Juma S; Muhsin J; Khamis IS; Hollenberg E; Mohammed KA; Kabole F; Ali SM; Rollinson D
PLoS Negl Trop Dis; 2019 May; 13(5):e0007268. PubMed ID: 31059495
[TBL] [Abstract][Full Text] [Related]
30. Female genital schistosomiasis burden and risk factors in two endemic areas in Malawi nested in the Morbidity Operational Research for Bilharziasis Implementation Decisions (MORBID) cross-sectional study.
Lamberti O; Kayuni S; Kumwenda D; Ngwira B; Singh V; Moktali V; Dhanani N; Wessels E; Van Lieshout L; Fleming FM; Mzilahowa T; Bustinduy AL
PLoS Negl Trop Dis; 2024 May; 18(5):e0012102. PubMed ID: 38718065
[TBL] [Abstract][Full Text] [Related]
31. Six rounds of annual praziquantel treatment during a national helminth control program significantly reduced schistosome infection and morbidity levels in a cohort of schoolchildren in Zimbabwe.
Mduluza T; Jones C; Osakunor DNM; Lim R; Kuebel JK; Phiri I; Manangazira P; Tagwireyi P; Mutapi F
PLoS Negl Trop Dis; 2020 Jun; 14(6):e0008388. PubMed ID: 32569278
[TBL] [Abstract][Full Text] [Related]
32. Detection of Schistosoma DNA in genital specimens and urine: A comparison between five female African study populations originating from S. haematobium and/or S. mansoni endemic areas.
Pillay P; Downs JA; Changalucha JM; Brienen EAT; Ramarokoto CE; Leutscher PDC; Vennervald BJ; Taylor M; Kjetland EF; Van Lieshout L
Acta Trop; 2020 Apr; 204():105363. PubMed ID: 32035055
[TBL] [Abstract][Full Text] [Related]
33. Application of Schistosomiasis Consortium for Operational Research and Evaluation Study Findings to Refine Predictive Modeling of
King CH; Yoon N; Wang X; Lo NC; Alsallaq R; Ndeffo-Mbah M; Li E; Gurarie D
Am J Trop Med Hyg; 2020 Jul; 103(1_Suppl):97-104. PubMed ID: 32400357
[TBL] [Abstract][Full Text] [Related]
34. Urogenital schistosomiasis in Cabo Delgado, northern Mozambique: baseline findings from the SCORE study.
Phillips AE; Gazzinelli-Guimarães PH; Aurelio HO; Dhanani N; Ferro J; Nala R; Deol A; Fenwick A
Parasit Vectors; 2018 Jan; 11(1):30. PubMed ID: 29316983
[TBL] [Abstract][Full Text] [Related]
35. The impact of mass drug administration on Schistosoma haematobium infection: what is required to achieve morbidity control and elimination?
Kura K; Hardwick RJ; Truscott JE; Toor J; Hollingsworth TD; Anderson RM
Parasit Vectors; 2020 Nov; 13(1):554. PubMed ID: 33203467
[TBL] [Abstract][Full Text] [Related]
36. Female genital schistosomiasis as a risk-factor for the transmission of HIV.
Feldmeier H; Krantz I; Poggensee G
Int J STD AIDS; 1994; 5(5):368-72. PubMed ID: 7819359
[TBL] [Abstract][Full Text] [Related]
37. Prevalence and intensity of genito-urinary schistosomiasis and associated risk factors among junior high school students in two local government areas around Zobe Dam in Katsina State, Nigeria.
Atalabi TE; Lawal U; Ipinlaye SJ
Parasit Vectors; 2016 Jul; 9(1):388. PubMed ID: 27388007
[TBL] [Abstract][Full Text] [Related]
38. Fine-scale-mapping of Schistosoma haematobium infections at the school and community levels and intermediate host snail abundance in the north of Pemba Island: baseline cross-sectional survey findings before the onset of a 3-year intervention study.
Trippler L; Ali SM; Ame SM; Hattendorf J; Suleiman KR; Ali MN; Juma S; Kabole F; Knopp S
Parasit Vectors; 2022 Aug; 15(1):292. PubMed ID: 35974353
[TBL] [Abstract][Full Text] [Related]
39. Modelling control of Schistosoma haematobium infection: predictions of the long-term impact of mass drug administration in Africa.
Gurarie D; Yoon N; Li E; Ndeffo-Mbah M; Durham D; Phillips AE; Aurelio HO; Ferro J; Galvani AP; King CH
Parasit Vectors; 2015 Oct; 8():529. PubMed ID: 26489408
[TBL] [Abstract][Full Text] [Related]
40. The Accuracy of Praziquantel Dose Poles for Mass Treatment of Schistosomiasis in School Girls in KwaZulu-Natal, South Africa.
Baan M; Galappaththi-Arachchige HN; Gagai S; Aurlund CG; Vennervald BJ; Taylor M; van Lieshout L; Kjetland EF
PLoS Negl Trop Dis; 2016 May; 10(5):e0004623. PubMed ID: 27139497
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
